Cornerstone Robotics closes approximately USD 200 million in oversubscribed funding round

November 10, 2025, Cornerstone Robotics, a leading and representative Chinese innovative surgical robot company (the"Company"), today announced the successful completion of an oversubscribed funding round of approximately USD 200 million.

This round attracted investment from Hong Kong Investment Corporation (HKIC), a global strategic investor, and a top-tier global sovereign wealth fund, alongside continued support from existing investors including Qiming Venture Partners, Bridgeone Capital, Gaorong Venture, and K2VC. The proceeds will be primarily used to accelerate the Company's commercialization efforts in China and overseas, as well as to advance the development and clinical registration of its next-generation products.

The investment from HKIC holds distinctive significance. As a patient capital investment institution wholly owned by and representing the HKSAR, HKIC adheres to rigorous market-based standards and a forward-looking global vision. It supports exceptional companies and projects that demonstrate cross-cycle, cross-generational, and cross-regional potential, empowering Hong Kong's economy, society, and industrial development, thereby contributing to global progress on this foundation.

As a technology innovation enterprise nurtured within the Guangdong-Hong Kong-Macao Greater Bay Area, Cornerstone Robotics' receipt of continued and substantial support from HKIC, which also led this investment round, serves not only as a powerful endorsement of the company's product innovation and global commercialization capabilities but also strongly demonstrates the firm confidence and long-term commitment of Hong Kong's local capital and even governmental forces in cultivating technology unicorns.

With its leading technology and promising prospects in the surgical robotics field, Cornerstone Robotics has successfully attracted a significant investment from a global strategic investor, infusing synergistic growth momentum into the company's critical development phases and global expansion strategy. This financing round also introduced a top-tier global sovereign wealth fund, whose participation will support Cornerstone Robotics in exploring overseas markets and facilitate market access and regional cooperation for its products. Existing investors, including Qiming Venture Partners, Bridgeone Capital, Gaorong Venture, and K2VC, also continued their support with additional investments, fully demonstrating the capital markets' strong recognition and steadfast confidence in Cornerstone Robotics' technological roadmap, commercialization progress, and long-term potential.

Since its founding in 2019, Cornerstone Robotics has consistently adhered to its vision of "Pioneering Medical Innovation with a Commitment to Global Health." Through full-stack in-house R&D and deep technological integration, the company has grown into a unicorn in China's innovative surgical robotics sector.

Cornerstone Robotics' core product, the Sentire® laparoscopic surgical robot, has not only received market approval from China's National Medical Products Administration (NMPA) but has also been deployed for clinical use in leading hospitals across mainland China, Hong Kong, and Europe. The company continues to translate its proprietary innovations into driving forces for the global smart healthcare ecosystem. Through collaborations with top-tier international medical and educational institutions, Cornerstone is deepening its presence in clinical training, technical demonstration, and academic exchange, empowering a new phase of enhanced global healthcare accessibility.